<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Richard EM</submitter><funding>NCATS NIH HHS</funding><funding>Telethon</funding><funding>NHLBI NIH HHS</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NINDS NIH HHS</funding><funding>Ataxia UK</funding><funding>Wellcome Trust</funding><pagination>2006-2016</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8546233</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>108(10)</volume><pubmed_abstract>Spermatogenesis-associated 5 like 1 (SPATA5L1) represents an orphan gene encoding a protein of unknown function. We report 28 bi-allelic variants in SPATA5L1 associated with sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microcephaly, developmental delay/intellectual disability, cerebral palsy, and/or epilepsy. Modeling indicated damaging effect of variants on the protein, largely via destabilizing effects on protein domains. Brain imaging revealed diminished cerebral volume, thin corpus callosum, and periventricular leukomalacia, and quantitative volumetry demonstrated significantly diminished white matter volumes in several individuals. Immunofluorescent imaging in rat hippocampal neurons revealed localization of Spata5l1 in neuronal and glial cell nuclei and more prominent expression in neurons. In the rodent inner ear, Spata5l1 is expressed in the neurosensory hair cells and inner ear supporting cells. Transcriptomic analysis performed with fibroblasts from affected individuals was able to distinguish affected from controls by principal components. Analysis of differentially expressed genes and networks suggested a role for SPATA5L1 in cell surface adhesion receptor function, intracellular focal adhesions, and DNA replication and mitosis. Collectively, our results indicate that bi-allelic SPATA5L1 variants lead to a human disease characterized by sensorineural hearing loss (SNHL) with or without a nonprogressive mixed neurodevelopmental phenotype.</pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.</pubmed_title><pmcid>PMC8546233</pmcid><funding_grant_id>K99 HL143036</funding_grant_id><funding_grant_id>UL1 TR002345</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>R01 NS106298</funding_grant_id><funding_grant_id>GSP15001</funding_grant_id><funding_grant_id>R00 HL143036</funding_grant_id><funding_grant_id>MR/S006753/1</funding_grant_id><funding_grant_id>MR/N027302/2</funding_grant_id><funding_grant_id>MR/N027302/1</funding_grant_id><funding_grant_id>ZHORVATH</funding_grant_id><funding_grant_id>R01 NS107428</funding_grant_id><funding_grant_id>104033/Z/14/Z</funding_grant_id><funding_grant_id>WT104033AIA</funding_grant_id><funding_grant_id>109915/A/15/Z</funding_grant_id><funding_grant_id>WT093205 MA</funding_grant_id><funding_grant_id>MR/N025431/2</funding_grant_id><funding_grant_id>MR/N010035/1</funding_grant_id><funding_grant_id>MR/V009346/1</funding_grant_id><funding_grant_id>G1000848</funding_grant_id><funding_grant_id>MR/N025431/1</funding_grant_id><funding_grant_id>WT093205</funding_grant_id><pubmed_authors>Yelton M</pubmed_authors><pubmed_authors>Ekstein J</pubmed_authors><pubmed_authors>Marsh APL</pubmed_authors><pubmed_authors>Amenta S</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Haack TB</pubmed_authors><pubmed_authors>Nordlie SM</pubmed_authors><pubmed_authors>Alhaddad B</pubmed_authors><pubmed_authors>Crunk A</pubmed_authors><pubmed_authors>Maroofian R</pubmed_authors><pubmed_authors>Abbott MA</pubmed_authors><pubmed_authors>Guida BS</pubmed_authors><pubmed_authors>Shetty S</pubmed_authors><pubmed_authors>Person R</pubmed_authors><pubmed_authors>Munchau A</pubmed_authors><pubmed_authors>Hahn A</pubmed_authors><pubmed_authors>Christodoulou J</pubmed_authors><pubmed_authors>Hufnagel RB</pubmed_authors><pubmed_authors>Jain M</pubmed_authors><pubmed_authors>Rodan LH</pubmed_authors><pubmed_authors>Bilguvar K</pubmed_authors><pubmed_authors>Sticht H</pubmed_authors><pubmed_authors>Smith-Hicks C</pubmed_authors><pubmed_authors>Nigro V</pubmed_authors><pubmed_authors>Grimmel M</pubmed_authors><pubmed_authors>Mane SM</pubmed_authors><pubmed_authors>Kruer MC</pubmed_authors><pubmed_authors>Korenke GC</pubmed_authors><pubmed_authors>Gecz J</pubmed_authors><pubmed_authors>Zollino M</pubmed_authors><pubmed_authors>Tucci A</pubmed_authors><pubmed_authors>Hiz S</pubmed_authors><pubmed_authors>van Eyk CL</pubmed_authors><pubmed_authors>Kaslin J</pubmed_authors><pubmed_authors>Ziegler A</pubmed_authors><pubmed_authors>Berry JG</pubmed_authors><pubmed_authors>Hirsch Y</pubmed_authors><pubmed_authors>Bakhtiari S</pubmed_authors><pubmed_authors>Chung WK</pubmed_authors><pubmed_authors>Begtrup A</pubmed_authors><pubmed_authors>Neidhardt J</pubmed_authors><pubmed_authors>Riazuddin S</pubmed_authors><pubmed_authors>Oktay Y</pubmed_authors><pubmed_authors>Gungor S</pubmed_authors><pubmed_authors>Guillen Sacoto MJ</pubmed_authors><pubmed_authors>Harper K</pubmed_authors><pubmed_authors>Tartaglia M</pubmed_authors><pubmed_authors>Webster RI</pubmed_authors><pubmed_authors>Jin SC</pubmed_authors><pubmed_authors>Rad A</pubmed_authors><pubmed_authors>Striano P</pubmed_authors><pubmed_authors>McWalter K</pubmed_authors><pubmed_authors>Torella A</pubmed_authors><pubmed_authors>Pinelli M</pubmed_authors><pubmed_authors>Pagnozzi A</pubmed_authors><pubmed_authors>Norton BY</pubmed_authors><pubmed_authors>Grossmann B</pubmed_authors><pubmed_authors>Makowski C</pubmed_authors><pubmed_authors>Lenz D</pubmed_authors><pubmed_authors>Marquardt I</pubmed_authors><pubmed_authors>Zara F</pubmed_authors><pubmed_authors>Worgan L</pubmed_authors><pubmed_authors>Vona B</pubmed_authors><pubmed_authors>Ahmed ZM</pubmed_authors><pubmed_authors>Mancini C</pubmed_authors><pubmed_authors>Rapp M</pubmed_authors><pubmed_authors>Kotzaeridou U</pubmed_authors><pubmed_authors>Kaiyrzhanov R</pubmed_authors><pubmed_authors>Mancardi MM</pubmed_authors><pubmed_authors>Corbett MA</pubmed_authors><pubmed_authors>Meitinger T</pubmed_authors><pubmed_authors>Marks WA</pubmed_authors><pubmed_authors>Weiden T</pubmed_authors><pubmed_authors>Kreuder F</pubmed_authors><pubmed_authors>Houlden H</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Blesson A</pubmed_authors><pubmed_authors>Lochmuller H</pubmed_authors><pubmed_authors>Wagner M</pubmed_authors><pubmed_authors>Hakonarson H</pubmed_authors><pubmed_authors>Claps Sepulveda DJ</pubmed_authors><pubmed_authors>Cohen JS</pubmed_authors><pubmed_authors>Fahey MC</pubmed_authors><pubmed_authors>Husain RA</pubmed_authors><pubmed_authors>Turnpenny P</pubmed_authors><pubmed_authors>Richard EM</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Marangi G</pubmed_authors><pubmed_authors>Steen C</pubmed_authors><pubmed_authors>Schnur RE</pubmed_authors><pubmed_authors>Chassevent A</pubmed_authors><pubmed_authors>Owczarek-Lipska M</pubmed_authors><pubmed_authors>Brunet T</pubmed_authors><pubmed_authors>Webber DL</pubmed_authors><pubmed_authors>Cornejo P</pubmed_authors><pubmed_authors>Magee H</pubmed_authors><pubmed_authors>Radio FC</pubmed_authors><pubmed_authors>MacLennan AH</pubmed_authors><pubmed_authors>Salpietro V</pubmed_authors><pubmed_authors>Comi A</pubmed_authors><pubmed_authors>Morleo M</pubmed_authors><pubmed_authors>Horvath R</pubmed_authors><pubmed_authors>Padilla-Lopez S</pubmed_authors><pubmed_authors>Grasshoff U</pubmed_authors><pubmed_authors>Zharkinbekova N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.</name><description>Spermatogenesis-associated 5 like 1 (SPATA5L1) represents an orphan gene encoding a protein of unknown function. We report 28 bi-allelic variants in SPATA5L1 associated with sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented with microcephaly, developmental delay/intellectual disability, cerebral palsy, and/or epilepsy. Modeling indicated damaging effect of variants on the protein, largely via destabilizing effects on protein domains. Brain imaging revealed diminished cerebral volume, thin corpus callosum, and periventricular leukomalacia, and quantitative volumetry demonstrated significantly diminished white matter volumes in several individuals. Immunofluorescent imaging in rat hippocampal neurons revealed localization of Spata5l1 in neuronal and glial cell nuclei and more prominent expression in neurons. In the rodent inner ear, Spata5l1 is expressed in the neurosensory hair cells and inner ear supporting cells. Transcriptomic analysis performed with fibroblasts from affected individuals was able to distinguish affected from controls by principal components. Analysis of differentially expressed genes and networks suggested a role for SPATA5L1 in cell surface adhesion receptor function, intracellular focal adhesions, and DNA replication and mitosis. Collectively, our results indicate that bi-allelic SPATA5L1 variants lead to a human disease characterized by sensorineural hearing loss (SNHL) with or without a nonprogressive mixed neurodevelopmental phenotype.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-05-31T13:00:14.6Z</modification><creation>2025-04-06T21:52:16.787Z</creation></dates><accession>S-EPMC8546233</accession><cross_references><pubmed>34626583</pubmed><doi>10.1016/j.ajhg.2021.08.003</doi></cross_references></HashMap>